Vaccine Contract Manufacturing Market Size, Share, Demand & Trends Analysis Report by 2032
Vaccine Contract Manufacturing Market - By Workflow (Downstream and Upstream), By Vaccine Type (Attenuated, Subunit, DNA, Inactivated, and Toxoid), By Application (Human and Veterinary), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024 - 2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 6.19 Billion | USD 17.25 Billion | 10.8% | 2023 |
Table Of Content
- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Type
- 1.3.2. Market Research Methodology
- Chapter 2. Executive Summary
- 2.1. Vaccine Contract Manufacturing Market, 2016–2026(USD Billion)
- 2.2. Vaccine Contract Manufacturing Market: Snapshot
- Chapter 3. Global Vaccine Contract Manufacturing Market– Vaccine Type Analysis
- 3.1. Vaccine Contract Manufacturing Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Launching of new products to the existing product line witnessed in the developed countries is likely to lead to surge in vaccine contract manufacturing activities across the emerging economies, thereby enhancing market size in these countries over the assessment timeframe.
- 3.2.2. Need for reducing spread of COVID across the globe has forced governments to focus on manufacturing vaccines. This has led to humungous expansion of vaccine manufacturing business along with boosting vaccine contract manufacturing industry over estimated timeline.
- 3.3. Porter’s Five Forces Analysis
- 3.4. Market Attractiveness Analysis
- 3.4.1. Market attractiveness analysis By Vaccine Type
- 3.4.2. Market attractiveness analysis By Workflow
- 3.4.3. Market attractiveness analysis By Application
- Chapter 4. Global Vaccine Contract Manufacturing Market– Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global Vaccine Contract Manufacturing Market: company market share, 2019
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New Product launches
- 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4. Research and development and Regional expansion
- 4.3. Price trend analysis
- 4.1. Company market share analysis
- Chapter 5. Global Vaccine Contract Manufacturing Market– Vaccine Type Analysis
- 5.1. Global Vaccine Contract Manufacturing Market overview: By Vaccine Type
- 5.1.1. Global Vaccine Contract Manufacturing Market share, By Vaccine Type , 2019 and 2026
- 5.2. Attenuated
- 5.2.1. Global Vaccine Contract Manufacturing Market by Attenuated, 2016–2026(USD Billion)
- 5.3. Subunit
- 5.3.1. Global Vaccine Contract Manufacturing Market by Subunit, 2016–2026(USD Billion)
- 5.4. DNA
- 5.4.1. Global Vaccine Contract Manufacturing Market by DNA, 2016–2026(USD Billion)
- 5.5. Inactivated
- 5.5.1. Global Vaccine Contract Manufacturing Market by Inactivated, 2016–2026(USD Billion)
- 5.6. Toxoid
- 5.6.1. Global Vaccine Contract Manufacturing Market by Toxoid, 2016–2026(USD Billion)
- 5.1. Global Vaccine Contract Manufacturing Market overview: By Vaccine Type
- Chapter 6. Global Vaccine Contract Manufacturing Market– Workflow Analysis
- 6.1. Global Vaccine Contract Manufacturing Market overview: By Workflow
- 6.1.1. Global Vaccine Contract Manufacturing Market share, By Workflow, 2019 and 2026
- 6.2. Downstream
- 6.2.1. Global Vaccine Contract Manufacturing Market by Downstream, 2016–2026(USD Billion)
- 6.3. Upstream
- 6.3.1. Global Vaccine Contract Manufacturing Market by Upstream, 2016–2026(USD Billion)
- 6.1. Global Vaccine Contract Manufacturing Market overview: By Workflow
- Chapter 7. Global Vaccine Contract Manufacturing Market– Application Analysis
- 7.1. Global Vaccine Contract Manufacturing Market overview: By Application
- 7.1.1. Global Vaccine Contract Manufacturing Market share, By Application, 2019 and 2026
- 7.2. Human
- 7.2.1. Global Vaccine Contract Manufacturing Market by Human, 2016–2026(USD Billion)
- 7.3. Veterinary
- 7.3.1. Global Vaccine Contract Manufacturing Market by Veterinary, 2016–2026(USD Billion)
- 7.1. Global Vaccine Contract Manufacturing Market overview: By Application
- Chapter 8. Company Profiles
- 8.1. Goodwin Biotechnulogy, Inc.
- 8.1.1. Overview
- 8.1.2. Financials
- 8.1.3. Product Portfolio
- 8.1.4. Business Strategy
- 8.1.5. Recent Developments
- 8.2. Minneapulis Medical Research Foundation (MMRF)
- 8.2.1. Overview
- 8.2.2. Financials
- 8.2.3. Product Portfolio
- 8.2.4. Business Strategy
- 8.2.5. Recent Developments
- 8.3. Suligenix Inc.
- 8.3.1. Overview
- 8.3.2. Financials
- 8.3.3. Product Portfolio
- 8.3.4. Business Strategy
- 8.3.5. Recent Development
- 8.4. FUJIFILM Diosynth Biotechnulogies
- 8.4.1. Overview
- 8.4.2. Financials
- 8.4.3. Product Portfolio
- 8.4.4. Business Strategy
- 8.4.5. Recent Development
- 8.5. Thomas Jefferson University
- 8.5.1. Overview
- 8.5.2. Financials
- 8.5.3. Product Portfolio
- 8.5.4. Business Strategy
- 8.5.5. Recent Development
- 8.6. Bavarian Nordic A/S
- 8.6.1. Overview
- 8.6.2. Financials
- 8.6.3. Product Portfolio
- 8.6.4. Business Strategy
- 8.6.5. Recent Development
- 8.7. Emergent BioSulutions
- 8.7.1. Overview
- 8.7.2. Financials
- 8.7.3. Product Portfolio
- 8.7.4. Business Strategy
- 8.7.5. Recent Development
- 8.8. BioMark
- 8.8.1. Overview
- 8.8.2. Financials
- 8.8.3. Product Portfolio
- 8.8.4. Business Strategy
- 8.8.5. Recent Development
- 8.9. Catalent Biulogics
- 8.9.1. Overview
- 8.9.2. Financials
- 8.9.3. Product Portfolio
- 8.9.4. Business Strategy
- 8.9.5. Recent Development
- 8.1. Goodwin Biotechnulogy, Inc.
Table Of Figures
List of Figures
1. Market research Type
2. Market research methodology
3. Global Vaccine Contract Manufacturing Market, 2016–2026(USD Billion)
4. Porter’s Five Forces Analysis
5. Global Vaccine Contract Manufacturing Marketattractiveness, By Vaccine Type
6. Global Vaccine Contract Manufacturing Marketattractiveness, By Workflow
7. Global Vaccine Contract Manufacturing Marketattractiveness, By Application
8. Global Vaccine Contract Manufacturing Marketshare by Vaccine Type ,2019 and 2026 (USD Billion)
9. Global Vaccine Contract Manufacturing Marketby Attenuated, 2016–2026(USD Billion)
10. Global Vaccine Contract Manufacturing Marketby Subunit, 2016–2026(USD Billion)
11. Global Vaccine Contract Manufacturing Marketby DNA, 2016–2026(USD Billion)
12. Global Vaccine Contract Manufacturing Marketby , Inactivated, 2016–2026(USD Billion)
13. Global Vaccine Contract Manufacturing Marketby Toxoid, 2016–2026(USD Billion)
14. Global Vaccine Contract Manufacturing Marketshare by Workflow ,2019 and 2026 (USD Billion)
15. Global Vaccine Contract Manufacturing Marketby Downstream, 2016–2026(USD Billion)
16. Global Vaccine Contract Manufacturing Marketby Upstream, 2016–2026(USD Billion)
17. Global Vaccine Contract Manufacturing Marketshare by Application ,2019 and 2026 (USD Billion)
18. Global Vaccine Contract Manufacturing Marketby Human, 2016–2026(USD Billion)
19. Global Vaccine Contract Manufacturing Marketby Veterinary, 2016–2026(USD Billion)
20. Global Vaccine Contract Manufacturing Marketshare, by Region, 2019 and 2026
21. North America Vaccine Contract Manufacturing Market, 2016–2026(USD Billion)
22. Europe Vaccine Contract Manufacturing Market, 2016–2026(USD Billion)
23. Asia Pacific Vaccine Contract Manufacturing Market, 2016–2026(USD Billion)
24. Latin America Vaccine Contract Manufacturing Market, 2016–2026(USD Billion)
25. The Middle East and Africa Vaccine Contract Manufacturing Market, 2016–2026(USD Billion)
Table Of Tables
List of Tables
1. Global Vaccine Contract Manufacturing Market: snapshot
2. Drivers of the Vaccine Contract Manufacturing Market: impact analysis
3. North America Vaccine Contract Manufacturing Market revenue, By Vaccine Type ,2016–2026(USD Billion)
4. North America Vaccine Contract Manufacturing Market revenue, By Workflow ,2016–2026(USD Billion)
5. North America Vaccine Contract Manufacturing Market revenue, By Application ,2016–2026(USD Billion)
6. The U.S. Vaccine Contract Manufacturing Market revenue, By Vaccine Type ,2016–2026(USD Billion)
7. The U.S. Vaccine Contract Manufacturing Market revenue, By Workflow ,2016–2026(USD Billion)
8. The U.S. Vaccine Contract Manufacturing Market revenue, By Application ,2016–2026(USD Billion)
9. Rest of North America Vaccine Contract Manufacturing Market revenue, By Vaccine Type ,2016–2026(USD Billion)
10. Rest of North America Vaccine Contract Manufacturing Market revenue, By Workflow ,2016–2026(USD Billion)
11. Rest of North America Vaccine Contract Manufacturing Market revenue, By Application ,2016–2026(USD Billion)
12. Europe Vaccine Contract Manufacturing Market revenue, By Vaccine Type ,2016–2026(USD Billion)
13. Europe Vaccine Contract Manufacturing Market revenue, By Workflow ,2016–2026(USD Billion)
14. Europe Vaccine Contract Manufacturing Market revenue, By Application ,2016–2026(USD Billion)
15. UK Vaccine Contract Manufacturing Market revenue, By Vaccine Type ,2016–2026(USD Billion)
16. UK Vaccine Contract Manufacturing Market revenue, By Workflow ,2016–2026(USD Billion)
17. UK Vaccine Contract Manufacturing Market revenue, By Application ,2016–2026(USD Billion)
18. France Vaccine Contract Manufacturing Market revenue, By Vaccine Type ,2016–2026(USD Billion)
19. France Vaccine Contract Manufacturing Market revenue, By Workflow ,2016–2026(USD Billion)
20. France Vaccine Contract Manufacturing Market revenue, By Application ,2016–2026(USD Billion)
21. Germany Vaccine Contract Manufacturing Market revenue, By Vaccine Type ,2016–2026(USD Billion)
22. Germany Vaccine Contract Manufacturing Market revenue, By Workflow ,2016–2026(USD Billion)
23. Germany Vaccine Contract Manufacturing Market revenue, By Application ,2016–2026(USD Billion)
24. Rest of Europe Vaccine Contract Manufacturing Market revenue, By Vaccine Type ,2016–2026(USD Billion)
25. Rest of Europe Vaccine Contract Manufacturing Market revenue, By Workflow ,2016–2026(USD Billion)
26. Rest of Europe Vaccine Contract Manufacturing Market revenue, By Application ,2016–2026(USD Billion)
27. Asia Pacific Vaccine Contract Manufacturing Market revenue, By Vaccine Type ,2016–2026(USD Billion)
28. Asia Pacific Vaccine Contract Manufacturing Market revenue, By Workflow ,2016–2026(USD Billion)
29. Asia Pacific Vaccine Contract Manufacturing Market revenue, By Application ,2016–2026(USD Billion)
30. China Vaccine Contract Manufacturing Market revenue, By Vaccine Type ,2016–2026(USD Billion)
31. China Vaccine Contract Manufacturing Market revenue, By Workflow ,2016–2026(USD Billion)
32. China Vaccine Contract Manufacturing Market revenue, By Application ,2016–2026(USD Billion)
33. Japan Vaccine Contract Manufacturing Market revenue, By Vaccine Type ,2016–2026(USD Billion)
34. Japan Vaccine Contract Manufacturing Market revenue, By Workflow ,2016–2026(USD Billion)
35. India Vaccine Contract Manufacturing Market revenue, By Vaccine Type ,2016–2026(USD Billion)
36. India Vaccine Contract Manufacturing Market revenue, By Workflow ,2016–2026(USD Billion)
37. India Vaccine Contract Manufacturing Market revenue, By Application ,2016–2026(USD Billion)
38. Rest of Asia Pacific Vaccine Contract Manufacturing Market revenue, By Vaccine Type ,2016–2026(USD Billion)
39. Rest of Asia Pacific Vaccine Contract Manufacturing Market revenue, By Workflow ,2016–2026(USD Billion)
40. Rest of Asia Pacific Vaccine Contract Manufacturing Market revenue, By Application ,2016–2026(USD Billion)
41. Latin America Vaccine Contract Manufacturing Market revenue, By Vaccine Type ,2016–2026(USD Billion)
42. Latin America Vaccine Contract Manufacturing Market revenue, By Workflow ,2016–2026(USD Billion)
43. Latin America Vaccine Contract Manufacturing Market revenue, By Application ,2016–2026(USD Billion)
44. Brazil Vaccine Contract Manufacturing Market revenue, By Vaccine Type ,2016–2026(USD Billion)
45. Brazil Vaccine Contract Manufacturing Market revenue, By Workflow ,2016–2026(USD Billion)
46. Brazil Vaccine Contract Manufacturing Market revenue, By Application ,2016–2026(USD Billion)
47. Rest of Latin America Vaccine Contract Manufacturing Market revenue, By Vaccine Type ,2016–2026(USD Billion)
48. Rest of Latin America Vaccine Contract Manufacturing Market revenue, By Workflow ,2016–2026(USD Billion)
49. Rest of Latin America Vaccine Contract Manufacturing Market revenue, By Application ,2016–2026(USD Billion)
50. The Middle East and Africa Vaccine Contract Manufacturing Market revenue, By Vaccine Type ,2016–2026(USD Billion)
51. The Middle East and Africa Vaccine Contract Manufacturing Market revenue, By Workflow ,2016–2026(USD Billion)
52. The Middle East and Africa Vaccine Contract Manufacturing Market revenue, By Application ,2016–2026(USD Billion)
53. Saudi Arabia Vaccine Contract Manufacturing Market revenue, By Vaccine Type ,2016–2026(USD Billion)
54. Saudi Arabia Vaccine Contract Manufacturing Market revenue, By Workflow ,2016–2026(USD Billion)
55. Saudi Arabia Vaccine Contract Manufacturing Market revenue, By Application ,2016–2026(USD Billion)
56. South Africa Vaccine Contract Manufacturing Market revenue, By Vaccine Type ,2016–2026(USD Billion)
57. South Africa Vaccine Contract Manufacturing Market revenue, By Workflow ,2016–2026(USD Billion)
58. South Africa Vaccine Contract Manufacturing Market revenue, By Application ,2016–2026(USD Billion)
59. Rest of the Middle East & Africa Vaccine Contract Manufacturing Market revenue, By Vaccine Type ,2016–2026(USD Billion)
60. Rest of the Middle East & Africa Vaccine Contract Manufacturing Market revenue, By Workflow ,2016–2026(USD Billion)
61. Rest of the Middle East & Africa Vaccine Contract Manufacturing Market revenue, By Application ,2016–2026(USD Billion)
Methodology
FrequentlyAsked Questions
Vaccine contract manufacturing involves third parties producing vaccines. It supports large-scale and faster vaccine supply
The global Vaccine Contract Manufacturing market is expected to be driven by the rising vaccine demand and outsourcing trends. Capacity expansion, regulatory expertise, and faster time-to-market support growth.
According to study, the global Vaccine Contract Manufacturing market size was worth around USD 6.19 Billion in 2023 and is predicted to grow to around USD 17.25 Billion By 2032.
The global Vaccine Contract Manufacturing market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 10.8% during the forecast period from 2024-2032.
The global Vaccine Contract Manufacturing industry is projected to be challenged by Challenges include capacity constraints, stringent quality standards, and technology transfer complexity.
The Opportunities include global immunization programs, biologics outsourcing, pandemic preparedness, and long-term vaccine demand will offer significant growth opportunities in the Vaccine Contract Manufacturing market.
Flexible, modular facilities; rapid scale-up platforms; quality-by-design and digital validation are the emerging trends and innovations impacting the Vaccine Contract Manufacturing market.
The global Vaccine Contract Manufacturing market is expected to be led by APAC during the forecast period.
Some of the prominent players operating in the global Vaccine Contract Manufacturing market are; Goodwin Biotechnology, Inc., Minneapolis Medical Research Foundation (MMRF), Soligenix Inc., FUJIFILM Diosynth Biotechnologies, Thomas Jefferson University, Bavarian Nordic A/S, Emergent BioSolutions, BioMark, and Catalent Biologics. among others and others.
The report explores crucial aspects of the Vaccine Contract Manufacturing market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients
